MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia.,
Saba, Nakhle S., Wong Deanna H., Tanios Georges, Iyer Jessica R., Lobelle-Rich Patricia, Dadashian Eman L., Liu Delong, Fontan Lorena, Flemington Erik K., Nichols Cydney M., et al.
, Cancer Res, 2017 Dec 15, Volume 77, Issue 24, p.7038-7048, (2017)
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.,
Cardenas, Mariano G., Yu Wenbo, Béguelin Wendy, Teater Matthew R., Geng Huimin, Goldstein Rebecca L., Oswald Erin, Hatzi Katerina, Yang Shao-Ning, Cohen Joanna, et al.
, J Clin Invest, 2016 Sep 01, Volume 126, Issue 9, p.3351-62, (2016)